Home

Site Search

News

Home

Home

Normal

Press release year list 2025 2024 2023 2022 2021 2020

06/25/2025

Forte Biosciences Announces Pricing of $75 Million Public Offering

06/24/2025

Forte Biosciences Announces Proposed Public Offering

06/23/2025

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

05/15/2025

Forte Biosciences, Inc. Announces Results and Provides Update

03/31/2025

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

02/03/2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Home
News
About Us
Investor Relations
Management
Contact Us

Headquarters

Forte Biosciences, Inc.
3060 Pegasus Park Dr.
Building 6
Dallas, TX 75247

inquiry@fortebiorx.com

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Forte Biosciences Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Forte Biosciences Inc to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Press Releases
Events
Presentations
SEC Filings
End of Day Stock Quote